Role of the addition of cabergoline to the management of acromegalic patients resistant to longterm treatment with octreotide LAR

Author： Vilar Lucio  

Publisher： Springer Publishing Company

ISSN： 1386-341X

Source： Pituitary, Vol.14, Iss.2, 2011-06, pp. : 148-156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of the combined cabergoline and octreotide treatment in a case of a dopamine-agonist resistant macroprolactinoma

By Fusco Alessandra  

Pituitary, Vol. 14, Iss. 4, 2011-12 ,pp. : 351-357

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of ECL cell carcinoids with octreotide LAR

By Fykse V.   Sandvik A. K.   Qvigstad G.   Falkmer S. E.   Syversen U.   Waldum H. L.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 7, 2004-07 ,pp. : 621-628

Informa Healthcare

Access to resources Recommend Favorite

In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5

By Gatto Federico  

Pituitary, Vol. 14, Iss. 2, 2011-06 ,pp. : 141-147

Springer Publishing Company

Access to resources Recommend Favorite

The Potential Role of Octreotide in the Treatment of Diabetic Retinopathy

By Grant Maria B.   Sergio Caballero Jr  

Treatments in Endocrinology, Vol. 4, Iss. 4, 2005-01 ,pp. : 199-203

Adis International

Access to resources Recommend Favorite

Role of Octreotide and Somatostatin in the Treatment of Intestinal Fistulae

By  

Digestion, Vol. 60, Iss. 2, 1999-04 ,pp. : 53-56

Karger

Access to resources Recommend Favorite